Keith Haffer

Person icon


Advantage Bio Consultants Inc, USA

Tel: 1-605-594-6255






Network Affiliate


Research Keywords: 

Animal models, adjuvants



Succesful researcher in vaccines for infectious diseases, mostly intracellular, pathogens (viruses, bacterial and parasites)


Related Websites



Key Publications

The effects of sonication, freezing and lyophilization on JMV leukosis strain. K. Haffer and M. Sevoian. Poultry Science 57: 95-98, 1978.

In vitro studies on the role of the macrophages of resistant and susceptible chickens with Marek's Disease. K. Haffer and M. Sevoian. Poultry Science 58:295-297, 1979.

The role of the macrophage in Marek's Disease. K. Haffer, M. Sevoian and M. Wilder.International Journal of Cancer 23 (5): 648-656, 1979.

Effects of age on cellular immune response in BALB/cJ mice: Increase in antibody-dependent T-lymphocyte mediated cytotoxicity. K. Haffer, M. Freeman and R. Watson. Mechanisms of
Ageing and Development 11 (4): 279-285, 1979.

Indirect hemagglutination test for pseudorabies antibody detection in swine. K. Haffer, D. Gustafson and C. Kanitz. J. Clinical Microbiology 11: 217-219, 1980.

Detection of pseudorabies virus antibodies: time of appearance by two serotests. K. Haffer, D. Gustafson and C. Kanitz. American Journal of Veterinary Research 41:1317-1318, 1980.

Modifications of cell-mediated immune responses by moderate dietary protein stress in immunologically immature and mature BALB/c mice. R. Watson and K. Haffer. Mechanisms of
Ageing and Development 12: 269-278, 1980.

Field test studies of the 2512 strain of IBD. K. Haffer. Avian Diseases 26: 847-851, 1982.

In vitro and in vivo studies with an avian reovirus derived from a temperature sensitive mutant clone. K. Haffer. Avian Diseases 28: 669- 676, 1984.

Feline leukemia vaccine: Evaluation of safety and efficacy against persistent viremia and tumor development. R. Sharpee, W. Beckenhauer, K. Haffer and R. Olsen. Compendium on
Continuing Education 8(4): 267-277, 1986.

Feline leukemia vaccine protection against viral latency. K. Haffer, R. Sharpee and W. Beckenhauer. Vaccine 5:133-135, 1987.

Feline Leukemia virus: Current status of the feline induced immune depression and immunoprevention. R. Olsen, M. Lewis, L. Lafrado, L. Mathes, K. Haffer and R. Sharpee.
Cancer and Metastasis Reviews: 6:243-260, 1987.

Feline leukemia virus vaccine: New developments. M. Lewis, L. Lafrado, K. Haffer, J. Gerber, R. Sharpee and R. Olsen. Vet. Micro. 17: 297-308, 1988.

Evaluation of immunosuppressive effect and efficacy of an improved-potency feline leukaemia vaccine. K. Haffer, W. Koertje, J. Derr and W.H. Beckenhauer. Vaccine 8: 12-16, 1990.

Review of the first feline leukemia virus vaccine. R. Pollock and K. Haffer. J Am Vet Med Assoc 199(10): 1406-1409, 1991.

Effects of Novel Vaccines on Weight Loss in Diet-Induced-Obese (DIO) Mice. K.N. Haffer. O Journal of Animal Science and Biotechnology 3:21, 2012.